Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos A Matos

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Advances in Experimental Medicine and Biology|February 11, 2018
Gene Therapies for Polyglutamine DiseasesCarlos A Matos, Vítor Carmona, Udaya-Geetha Vijayakumar, et al.
The Journal of Cell Biology|February 17, 2016
Ataxin-3 phosphorylation decreases neuronal defects in spinocerebellar ataxia type 3 modelsCarlos A Matos, Clévio Nóbrega, Susana R Louros, et al.
Human Molecular Genetics|September 17, 2018
Cordycepin activates autophagy through AMPK phosphorylation to reduce abnormalities in Machado-Joseph disease modelsAdriana Marcelo, Filipa Brito, Sara Carmo-Silva, et al.
Biochimica Et Biophysica Acta|June 16, 2015
SUMOylation of the brain-predominant Ataxin-3 isoform modulates its interaction with p97Bruno Almeida, Isabel A Abreu, Carlos A Matos, et al.
BMC Research Notes|April 12, 2020
The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington's diseaseClévio Nóbrega, André Conceição, Rafael G Costa, et al.
Acta Neuropathologica|June 15, 2019
Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxiaClévio Nóbrega, Liliana Mendonça, Adriana Marcelo, et al.
Cell Death & Disease|November 30, 2021
Autophagy in Spinocerebellar ataxia type 2, a dysregulated pathway, and a target for therapyAdriana Marcelo, Inês T Afonso, Ricardo Afonso-Reis, et al.
Cell Death & Disease|November 10, 2025
Molecular hallmarks of neurodegeneration in polyglutamine spinocerebellar ataxiasClévio Nóbrega, Adriana Marcelo, Ana Teresa Rajado, et al.
Brain : a Journal of Neurology|December 13, 2022
The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficitsRebekah Koppenol, André Conceição, Inês T Afonso, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Advances in Experimental Medicine and Biology|February 11, 2018
Gene Therapies for Polyglutamine DiseasesCarlos A Matos, Vítor Carmona, Udaya-Geetha Vijayakumar, et al.
The Journal of Cell Biology|February 17, 2016
Ataxin-3 phosphorylation decreases neuronal defects in spinocerebellar ataxia type 3 modelsCarlos A Matos, Clévio Nóbrega, Susana R Louros, et al.
Human Molecular Genetics|September 17, 2018
Cordycepin activates autophagy through AMPK phosphorylation to reduce abnormalities in Machado-Joseph disease modelsAdriana Marcelo, Filipa Brito, Sara Carmo-Silva, et al.
Biochimica Et Biophysica Acta|June 16, 2015
SUMOylation of the brain-predominant Ataxin-3 isoform modulates its interaction with p97Bruno Almeida, Isabel A Abreu, Carlos A Matos, et al.
BMC Research Notes|April 12, 2020
The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington's diseaseClévio Nóbrega, André Conceição, Rafael G Costa, et al.
Acta Neuropathologica|June 15, 2019
Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxiaClévio Nóbrega, Liliana Mendonça, Adriana Marcelo, et al.
Cell Death & Disease|November 30, 2021
Autophagy in Spinocerebellar ataxia type 2, a dysregulated pathway, and a target for therapyAdriana Marcelo, Inês T Afonso, Ricardo Afonso-Reis, et al.
Cell Death & Disease|November 10, 2025
Molecular hallmarks of neurodegeneration in polyglutamine spinocerebellar ataxiasClévio Nóbrega, Adriana Marcelo, Ana Teresa Rajado, et al.
Brain : a Journal of Neurology|December 13, 2022
The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficitsRebekah Koppenol, André Conceição, Inês T Afonso, et al.
Pageof 2